Denali Therapeutics Inc (DNLI)

Sales/Maturities of Investments

$799.11M

TTM · Period ending: · USD

DNLI logo

DNLI Sales/Maturities of Investments

Latest reported$799.11M
DNLI TTM Sales/Maturities of Investments ($14.00M → $799.11M)
High-resolution chart · PNG

DNLI sales/maturities of investments history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Denali Therapeutics Inc Sales/Maturities of Investments — Trailing twelve months (TTM) (USD)
Period endingSales/Maturities of Investments (USD)
799,113,000
764,294,000
706,046,000
782,046,000
872,965,000
935,752,000
1,157,120,000
1,295,120,000
1,698,238,000
2,025,282,000
2,075,947,000
1,950,947,000
1,494,168,000
1,174,771,000
991,486,000
821,236,000
969,959,000
1,219,812,000
1,409,812,000
1,447,862,000
1,307,300,000
965,156,000
665,357,000
629,272,000
604,222,000
572,237,000
535,327,000
436,939,000
394,014,000
350,393,000
273,901,000
215,634,000
166,497,000
135,597,000
141,498,000
116,438,000
81,050,000
47,200,000
14,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.